Adage Capital Management, L.P.

Insider Reports History

Entity
Company
Location
200 Clarendon Street, 52 Nd Floor, Boston, MA
Signature
/s/ Adage Capital Management, L.P.; By: its general partner Adage Capital Partners LLC; By its managing member Robert Atchinson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adage Capital Management, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Solid Biosciences Inc. 10%+ Owner Common Stock, $0.001 par value per share 4.25M $32.1M $7.56 Feb 18, 2025 Indirect
ABEONA THERAPEUTICS INC. 10%+ Owner Pre-funded Warrant (right to buy) 2.95M $12M $4.07 May 7, 2024 Indirect
EyePoint Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.001 per share ("Common Stock") 5.16M Apr 18, 2024 Indirect

Insider Reports Filed by Adage Capital Management, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SLDB Solid Biosciences Inc. Feb 18, 2025 1 $1.91M 4 Feb 19, 2025 10%+ Owner
SLDB Solid Biosciences Inc. Feb 18, 2025 0 $0 3 Feb 19, 2025 10%+ Owner
ABEO ABEONA THERAPEUTICS INC. May 7, 2024 1 $12M 4 May 8, 2024 10%+ Owner
EYPT EyePoint Pharmaceuticals, Inc. Apr 18, 2024 0 $0 3 Apr 22, 2024 10%+ Owner